Crossmark

From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs

Crossref DOI link: https://doi.org/10.15252/emmm.201809854

Published Online: 2019-08

Published Print: 2019-09

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

McIntyre, Rebecca L

Daniels, Eileen G

Molenaars, Marte

Houtkooper, Riekelt H https://orcid.org/0000-0001-9961-0842
Janssens, Georges E https://orcid.org/0000-0003-2104-8145
Funding

Funding for this research was provided by:

H2020 European Research Council (638290)

ZonMw (91715305)

Federation of European Biochemical Societies
License Information

Version of Record valid from 2019-08-01
More Information

Publication History

Received: 2018-09-24

Accepted: 2019-07-11

Published: 2019-08-01